It is going to take some time. You just don't randomly choose companies to try and sell your product. You need to find companies/sales teams that do not already represent a competing product. They also need to find a sales team that is not tied to the hip to pharmaceuticals. Pharmaceutical companies are famous for providing great perks to the sales force to encourage and tip the hat towards their product. They have deep pockets.
They most likely need to find smaller distributors that are hungry and enthusiastic. But finding smaller distributors is more difficult and more time consuming.
The opioid epidemic news should assist ENDV in getting their product out there. But it will take some re-training in the minds of the medical professionals. Pills have been the way of life for a long time.
Remember, the Sofpulse is not a retail item. It is manufactured and marketed for post surgery pain and swelling. It needs to be marketed to the medical professionals who need to suggest it as a treatment option to the patients.
The public does need to be made aware of this though. It would help if patients knew of this item prior to surgery so that they can have it available for use without being educated of it at the time of post op healing. The question is what is the best way though. You don't want ENDV randomly throwing money into the wind for ineffective marketing.
You also need to have inventory on hand prior to fully marketing the item. You need to have inventory when the orders roll in. Maybe ENDV is slowly getting units made in advance of a marketing campaign or signing up additional distributors?
Have you contacted IR to ask any of these type of questions?
News 
Market Data 
Discover 
